SEGMENT REPORTING (Tables)

6 Months Ended

Jun. 30, 2026

Segment Reporting [Abstract]

Segment Reporting

The following table reflects results of operations of the Company’s reportable segment (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Infusion services net revenue	$	1,416,777	$	1,393,008	$	2,742,784	$	2,704,189
Other revenue (1)	25,623		23,077		50,270		44,868
Total Option Care Health revenue	1,442,400		1,416,085		2,793,054		2,749,057
(Expense) Income:
Cost of net revenues - drugs	(1,024,241)		(1,004,610)		(1,973,605)		(1,937,678)
Salaries, benefits, and other employee expense	(213,631)		(212,195)		(430,224)		(417,887)
Other segment items (2)	(101,936)		(100,329)		(199,181)		(199,607)
Depreciation and amortization expense	(17,452)		(16,241)		(32,359)		(31,987)
Interest expense, net	(14,020)		(14,447)		(27,324)		(27,678)
Equity in earnings of joint ventures	1,704		1,395		3,393		3,124
Other, net	1,163		(797)		1,236		(4,927)
Income tax expense	(20,074)		(18,338)		(35,734)		(35,152)
Net Income	$	53,913	$	50,523	$	99,256	$	97,265

(1) Represents business activities related to other miscellaneous revenue streams.

(2) Other segment items includes expenses for medical supplies, delivery and packaging, leases, professional services, and other expenses.